The FDA has launched a new pilot project to inform the development of a new electronic, interoperable track-and-trace system, anticipated for 2023, as part of the Drug Supply Chain Security Act (DSCSA).
The FDA has launched a new pilot project to inform the development of a new electronic, interoperable track-and-trace system, anticipated for 2023, as part of the Drug Supply Chain Security Act (DSCSA).